Table 3.
Complictaions in patients with epilepsy and COVID-19.
| Total |
NS group |
RS group |
EH group |
P | |
|---|---|---|---|---|---|
| N = 30 | N = 13 (43.3%) | n = 10 (33.3%) | n = 7 (23.3%) | ||
| Numbers of complications | 5.5 (3–9) | 7 (3.5–9) | 5 (3.25–9.25) | 4 (0–7) | 0.642 |
| 0 | 4 (13.3%) | 0 (0%) | 1 (10%) | 3 (42.9%) | 0.082 |
| 1–5 | 11 (36.7%) | 5 (38.5%) | 5 (50%) | 1 (14.3%) | |
| 6–10 | 14 (46.7%) | 8 (61.5%) | 3 (30%) | 3 (42.9%) | |
| >10 | 1 (3.3%) | 0 (0%) | 1 (10%) | 0 (0%) | |
| Complications | |||||
| Hypertension | 18 (60%) | 10 (76.9%) | 5 (50%) | 3 (42.9%) | 0.261 |
| Respiratory distress or failure | 14 (46.7%) | 6 (46.2%) | 6 (60%) | 2 (28.6%) | 0.517 |
| Cerebral hemorrhage | 13 (43.3%) | 8 (61.5%) | 4 (40%) | 1 (14.3%) | 0.134 |
| Gastrointestinal ulcer | 13 (43.3%) | 6 (46.2%) | 5 (50%) | 2 (28.6%) | 0.721 |
| Bacterial pneumonia | 13 (43.3%) | 7 (53.8%) | 4 (40%) | 2 (28.6%) | 0.645 |
| Hepatic injury | 10 (33.3%) | 5 (38.5%) | 4 (40%) | 1 (14.3%) | 0.55 |
| Cerebral infarction | 6 (20%) | 3 (23.1%) | 2 (20%) | 1 (14.3%) | 1 |
| Hypoproteinemia | 6 (20%) | 2 (15.4%) | 3 (30%) | 1 (14.3%) | 0.724 |
| Kidney failure | 6 (20%) | 4 (30.8%) | 0 (0%) | 2 (28.6%) | 0.121 |
| Brain truauma | 5 (16.7%) | 3 (23.1%) | 2 (20%) | 0 | 0.572 |
| Cerebrovascular malformation | 5 (16.7%) | 3 (23.1%) | 2 (20%) | 0 (0%) | 0.572 |
| Coronary heart disease | 5 (16.7%) | 4 (30.8%) | 0 (0%) | 1 (14.3%) | 0.161 |
| Diabetes | 5 (16.7%) | 3 (23.1%) | 1 (10%) | 1 (14.3%) | 0.828 |
| Circulatory failure | 4 (13.3%) | 3 (23.1%) | 1 (10%) | 0 (0%) | 0.523 |
| Pneumonectasis | 3 (10%) | 1 (7.7%) | 1 (10%) | 1 (14.3%) | 1 |
| Electrolyte disturbance | 3 (10%) | 3 (23.1%) | 0 (0%) | 0 (0%) | 0.228 |
| Anemia | 3 (10%) | 2 (15.4%) | 1 (10%) | 0 (0%) | 0.776 |
| Atrial fibrillation | 2 (6.7%) | 1 (7.7%) | 0 (0%) | 1 (14.3%) | 0.701 |
| Sepsis | 2 (6.7%) | 1 (7.7%) | 1 (10%) | 0 (0%) | 1 |
| Anxiety | 2 (6.7%) | 1 (7.7%) | 0 (0%) | 1 (14.3%) | 0.701 |
| Hypoglycemia | 1 (3.3%) | 1 (7.7%) | 0 (0%) | 0 (0%) | 1 |
| Pituitary adenoma | 1 (3.3%) | 0 (0%) | 1 (10%) | 0 (0%) | 0.567 |
| Hypothyroidism | 1 (3.3%) | 0 (0%) | 1 (10%) | 0 (0%) | 0.567 |
| Acute pancreatitis | 1 (3.3%) | 1 (7.7%) | 0 (0%) | 0 (0%) | 1 |
| Tumor of breast | 1 (3.3%) | 1 (7.7%) | 0 (0%) | 0 (0%) | 1 |
| Lung cancer | 1 (3.3%) | 0 (0%) | 0 (0%) | 1 (14.3%) | 0.233 |
| Thrombus of lower extremity veins | 2 (6.7%) | 1 (7.7%) | 0 (0%) | 1 (14.3%) | 0.701 |
| Pulmonary embolism | 1 (3.3%) | 1 (7.7%) | 0 (0%) | 0 (0%) | 1 |
| Lupus nephritis | 1 (3.3%) | 1 (7.7%) | 0 (0%) | 0 (0%) | 1 |
NS group: New-onset seizure group without epilepsy history; RS group: recurrent seizure with epilepsy history; EH group: epilepsy history group.
P less than 0.05 was considered statistcally significant.